Evoke Pharma (EVOK) Tops Q4 EPS by 7c

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.12), $0.07 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
• Getty Images and Shutterstock merger to end after UK regulator's conditions
• Trump discloses over $1.4 billion in crypto income in 2025 filing